Polymeric Nanoparticles Enhance the Ability of Deferoxamine To Deplete Hepatic and Systemic Iron
- 7 August 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 18 (9) , 5782-5790
Abstract
Chelators are commonly used to remove excess iron in iron-loading disorders. Deferoxamine (DFO) is an effective and safe iron chelator, but an onerous parenteral administration regimen limits its routine use. To develop more effective methods for delivering iron chelators, we examined whether amphiphilic copolymer nanoparticles (NPs), could deliver DFO more efficiently. Physical characterization showed a uniform and stable preparation of DFO nanoparticles (DFO-NPs) with an average diameter of 105.3 nm. In macrophage (RAW264.7) and hepatoma (HepG2) cell lines, DFO-NPs proved more effective at depleting iron than free DFO. In wild-type mice previously loaded with iron dextran, as well as Hbbth3/+ and Hfe-/- mice, which are predisposed to iron loading, DFO-NPs (40 mg/kg DFO; alternate days; 4 weeks) reduced hepatic iron levels by 71, 46 and 37% respectively, whereas the equivalent values for free DFO were 53, 7 and 15%. Staining for tissue iron and urinary iron excretion confirmed these findings. Pharmacokinetic analysis showed that NP-encapsulated DFO had a much longer elimination half-life than free DFO (48.63 ± 28.80 vs 1.46 ± 0.59 h), and that DFO-NPs could be readily taken up by tissues, and, in particular, by hepatic Kupffer cells. In vitro, DFO-NPs were less toxic to several cell lines than free DFO, and in vivo they did not elicit any specific inflammatory responses or histological changes. Our results suggest that using a nanoformulation of DFO is a valuable strategy for improving its efficiency as an iron chelator and that this could broaden its clinical use for the treatment of human iron overload disorders.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2018YFA0208900)
- National Health and Medical Research Council (APP1024230, APP1107095)
- Queensland Government (QCAS03916-17RD6)
- National Natural Science Foundation of China (31730032, 31471035)
- Chinese Academy of Sciences (QCAS03916-17RD6, QYZDJ-SSW-SLH022)
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z161100000116035)
This publication has 45 references indexed in Scilit:
- Brain targeted delivery of paclitaxel using endogenous ligandAsian Journal of Pharmaceutical Sciences, 2016
- Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complicationsAnnals of Hematology, 2014
- Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agentsBiomaterials, 2010
- Conjugates of Desferrioxamine B (DFOB) with Derivatives of Adamantane or with Orally Available Chelators as Potential Agents for Treating Iron OverloadJournal of Medicinal Chemistry, 2009
- Mechanisms of iron loading and toxicityAmerican Journal of Hematology, 2007
- Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInternational Journal of Pharmaceutics, 2006
- Intraocular injection of tamoxifen‐loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitisEuropean Journal of Immunology, 2004
- Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA–mPEG nanoparticlesInternational Journal of Pharmaceutics, 2001
- Carbonyl-iron supplementation induces hepatocyte nuclear changes in BALB/CJ male miceJournal of Hepatology, 1999
- Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A reviewBiochimie, 1998